We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Compugen Announces Discovery of Blood Based Biomarker for Diagnosis of Lung Cancer

News   Apr 30, 2008

 
Compugen Announces Discovery of Blood Based Biomarker for Diagnosis of Lung Cancer
 
 
 

RELATED ARTICLES

Fatty Liver Disease Affects Cells' Energy Factories

News

Nonalcoholic fatty liver disease produces no noticeable symptoms, but one out of every five people with it will go on to develop a more serious conditions such as nonalcoholic steatohepatosis and cirrhosis. Three new studies investigate how mitochondrial energy production is altered by the progress of fatty liver disease.

READ MORE

New Approach Improves Detection of Diseases at Birth

News

Combining metabolic and DNA testing approaches is a way forward for newborn screening, false positives reduced by half.

READ MORE

Cloud Platform Makes Metabolic Data Properly Public

News

Patients want to see their medical information. Researchers want to share their data. A new cloud-based analysis platform allows scientists to quantify molecules from biological samples and make their results publicly available to anyone with a computer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE